Disclosed are isomers of N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-phenyl] acetamide. Processes for making the isomers are also disclosed. Also disclosed is the use of the isomers for treating bronchoconstriction associated with reversible obstructive airways disease.